Related to Exploring Biology in Space May See a Slowdown with the End of NASA’s Shuttle Missions

• Pharma Touting Phase II/III Wins in Run-Up to ASCO
  
• VC Firm Partners with Amgen, Novartis to Form 15+ Biotech Startups
  
• Regenerative Sciences Grants NeoStem Exclusive Asia License to Regenexx
  
• U.K. Team Scoops Up Roughly $6M to Develop Cell-Based Methods for Skeletal Repair
  
• U.K. Team Scoops Up Roughly $6M to Develop Cell-Based Methods for Skeletal Repair
  
• GSK to Pay $120M for Commercial Rights to Amgen’s Lead mAb
  
• Amgen Set Back with Prolia Approval in Postmenopausal Osteoporosis
  
• Scientists Pinpoint a Way to Stimulate Bone Formation Independent of Bone Destruction
  
• BioMimetic Strengthens Arrangement with Novartis for Exclusive Supply of Recombinant Human Platelet-Derived Growth Factor
  
• Adocia Raises Over $20M to Take BioChaperone Growth-Factor Treatments into Phase I Trials
  
• American Medical Systems and Tissue Genesis to Study Regenerative Potential of Adipose Cells in Pelvic Health Disorders
  
• University of Cardiff Spin-Out to Develop Cell-Based Cartilage-Replacement Therapy
  
• BioTime Sets Up OrthoCyte Subsidiary for Stem Cell Based Orthopedic Products
  
• Medtronic Pads Regenerative Medicine Franchise with $123M Purchase of Osteotech
  
• UCB and Plasticell Partner to Identify Compounds for SC Research and Cell Therapeutics
  
• Amgen’s Xgeva Approved by EC for Treating SREs in Adults with Solid Tumor-Related Bone Metastases
  
• Picture Perfect Cartilage Analysis
  
• Wright Closes Up-To-$380M BioMimetic Purchase
  
• NIH Gives Out $1.3M in Grants to Support Biomedical Research in Space
  
• UCB and Amgen Partner with NASA to Evaluate Antibody Against Bone Loss